Literature DB >> 21865885

Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle.

Daniel Skuk1, Marlyne Goulet, Jacques P Tremblay.   

Abstract

A major restriction of the intramuscular transplantation of myoblasts is that the grafted cells fuse mostly with myofibers along the injection trajectories. This has been attributed to a "lack of migration ability" of the grafted myoblasts. It has been assumed that grafted myoblasts remain motionless in the sites of delivery and fuse only with myofibers with which they come into contact. In the present study, we analyzed this phenomenon in 17 cynomolgus monkeys. We found that intramuscularly injected myoblasts within 1 hour after their injection are mainly located in the perimysium and not distributed along the injection trajectories. This suggested that the grafted myoblasts later migrate from the perimysium to fuse with myofibers that are damaged by the injections. Therefore, we analyzed whether β-galactosidase-labeled myoblasts injected subcutaneously over skeletal muscles migrate in needle-damaged and nondamaged muscle regions. We observed that grafted myoblasts migrated up to 1cm in depth from the muscle surface into the muscles, although they seemingly fused mainly with damaged myofibers. Our findings suggest that myoblast transplantation is not necessarily restricted bya "lack of migration ability" of the grafted cells but by the fact that myoblasts fuse with regenerating myofibers and not with undamaged myofibers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865885     DOI: 10.1097/NEN.0b013e31822a6baa

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

1.  Clarifying misconceptions about myoblast transplantation in myology.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  Mol Ther       Date:  2014-05       Impact factor: 11.454

2.  Linker of nucleoskeleton and cytoskeleton (LINC) complex-mediated actin-dependent nuclear positioning orients centrosomes in migrating myoblasts.

Authors:  Wakam Chang; Susumu Antoku; Cecilia Östlund; Howard J Worman; Gregg G Gundersen
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

3.  Obestatin Increases the Regenerative Capacity of Human Myoblasts Transplanted Intramuscularly in an Immunodeficient Mouse Model.

Authors:  Icia Santos-Zas; Elisa Negroni; Kamel Mamchaoui; Carlos S Mosteiro; Rosalia Gallego; Gillian S Butler-Browne; Yolanda Pazos; Vincent Mouly; Jesus P Camiña
Journal:  Mol Ther       Date:  2017-07-24       Impact factor: 11.454

4.  Semitendinosus myopathy and treatment with adipose-derived stem cells in working German shepherd police dogs.

Authors:  Melissa A Gibson; S Gary Brown; Nancy O Brown
Journal:  Can Vet J       Date:  2017-03       Impact factor: 1.008

5.  Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Authors:  Judith Lorant; Charlotte Saury; Cindy Schleder; Florence Robriquet; Blandine Lieubeau; Elisa Négroni; Isabelle Leroux; Lucie Chabrand; Sabrina Viau; Candice Babarit; Mireille Ledevin; Laurence Dubreil; Antoine Hamel; Armelle Magot; Chantal Thorin; Laëtitia Guevel; Bruno Delorme; Yann Péréon; Gillian Butler-Browne; Vincent Mouly; Karl Rouger
Journal:  Mol Ther       Date:  2017-10-20       Impact factor: 11.454

Review 6.  Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle.

Authors:  Olivier Boyer; Gillian Butler-Browne; Hector Chinoy; Giulio Cossu; Francesco Galli; James B Lilleker; Alessandro Magli; Vincent Mouly; Rita C R Perlingeiro; Stefano C Previtali; Maurilio Sampaolesi; Hubert Smeets; Verena Schoewel-Wolf; Simone Spuler; Yvan Torrente; Florence Van Tienen
Journal:  Front Genet       Date:  2021-08-02       Impact factor: 4.599

7.  Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy.

Authors:  Jinhong Meng; Marc Moore; John Counsell; Francesco Muntoni; Linda Popplewell; Jennifer Morgan
Journal:  Mol Ther Methods Clin Dev       Date:  2022-05-02       Impact factor: 5.849

8.  Phospho-tyrosine phosphatase inhibitor Bpv(Hopic) enhances C2C12 myoblast migration in vitro. Requirement of PI3K/AKT and MAPK/ERK pathways.

Authors:  Georgi A Dimchev; Nasser Al-Shanti; Claire E Stewart
Journal:  J Muscle Res Cell Motil       Date:  2013-04-04       Impact factor: 2.698

9.  Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.

Authors:  Jane T Seto; Niclas E Bengtsson; Jeffrey S Chamberlain
Journal:  Curr Pediatr Rep       Date:  2014-06-01

10.  Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusion.

Authors:  Franka Messner; Marco Thurner; Stefan Schneeberger; Theresa Hautz; Jule Müller; Michael Blumer; Julia Hofmann; Rainer Marksteiner; Sebastien Couillard-Despres; Jakob Troppmair; Dietmar Öfner
Journal:  Stem Cell Res Ther       Date:  2021-02-24       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.